Stem cell therapy for Stroke Recovery — for patients from Canada

If you are researching Stroke Recovery treatment from Canada, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €5,500–€18,400. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.

How Stroke Recovery is treated

Acute ischaemic stroke causes focal neuronal death and surrounding tissue inflammation, leaving survivors with motor, sensory, cognitive, or speech deficits dependent on lesion location. Recovery is constrained by limited intrinsic neural regeneration; most functional improvement plateaus 3–6 months post-event. Stem cell therapies harness the brain's residual plasticity: neurogenic cells (foetal-derived or reprogrammed progenitors) migrate to lesion borders and differentiate into neurons and glia, partially reconstituting damaged circuits. Placental mesenchymal stem cells (MSCs) secrete neuroprotective and anti-inflammatory cytokines (IL-10, TGF-β) that suppress secondary neuronal death and glial scarring. Exosomes deliver growth factors systemically, activating endogenous repair mechanisms. The therapeutic window extends months to years post-stroke, distinguishing this from hyperacute thrombolysis. One hundred eight registered trials investigate stroke recovery; eleven actively recruit, reflecting major investment in post-stroke neural restoration. It is delivered under a physician-led protocol and designed to complement your existing care.

Your cost from Canada

Cost ranges are indicative market figures for planning, not quotes.